Vimarsana
Biggest News Aggregation in the World

Page 3 - For Global News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from For Global. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In For Global Today - Breaking & Trending Today

Coherus and Junshi Biosciences Announce FDA Approval of - Vimarsana News

Coherus and Junshi Biosciences Announce FDA Approval of

–  LOQTORZI is the first and only FDA-approved treatment for NPC – – Indicated in combination with chemotherapy for 1st line treatment and as monotherapy...

Junshi Biosciences Announces 2023 Interim Financial Results and Provides Corporate Updates - Vimarsana News

Junshi Biosciences Announces 2023 Interim Financial Results and Provides Corporate Updates

SHANGHAI, China, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leadi...

2024 KTM Duke 390 Unveiled For Global Market, India Launch Soon - Vimarsana News

2024 KTM Duke 390 Unveiled For Global Market, India Launch Soon

2024 KTM Duke 390 has been unveiled with a bigger engine, advanced features, and bold design, setting new standards in motorcycling excellence.

Source: news18.com
Junshi Biosciences Announces Collaboration with Dr. Reddy's to Develop and Commercialize Toripalimab in 21 Countries - Vimarsana News

Junshi Biosciences Announces Collaboration with Dr. Reddy's to Develop and Commercialize Toripalimab in 21 Countries

SHANGHAI, China, May 07, 2023 -- Shanghai Junshi Biosciences Co., Ltd announced a collaboration with Dr. Reddy’s Laboratories Limited to develop and commercialize toripalimab, the anti-PD-1... | May 7, 2023

Junshi Biosciences, Dr. Reddy's to develop and market toripalimab - Vimarsana News

Junshi Biosciences, Dr. Reddy's to develop and market toripalimab

Shanghai Junshi Biosciences and Dr. Reddy’s Laboratories have partnered for the development and commercialisation of toripalimab.